MCQOPTIONS
Saved Bookmarks
MCQOPTIONS
| 1. |
Imipenem is marketed in combination with Cilastatin, a drug that - |
| A. | Inhibits the degradation of imipenem by beta lactamase |
| B. | Inhibits the degradation of imipenem by a renal tubular dipeptidase |
| C. | Inhibits the degradation of imipenem by carbonic anhydrase in renal brush border |
| D. | Inhibits the degradation of imipenem by DNA gyrase |
| Answer» C. Inhibits the degradation of imipenem by carbonic anhydrase in renal brush border | |